We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+21.94%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$128M
Cap. Flow
+$26.2M
Cap. Flow %
2.17%
Top 10 Hldgs %
56.76%
Holding
362
New
28
Increased
88
Reduced
207
Closed
28

Top Buys

Rank Stock Value
1
TME icon
Tencent Music
TME
+$28.3M
2
LEGN icon
Legend Biotech
LEGN
+$20.2M
3
TCOM icon
Trip.com Group
TCOM
+$16M
4
STAA icon
STAAR Surgical
STAA
+$10.7M
5
ZLAB icon
Zai Lab
ZLAB
+$7.74M

Top Sells

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$21.9M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.8M
3
NIO icon
NIO
NIO
+$10.3M
4
LI icon
Li Auto
LI
+$8.53M
5
BZ icon
Kanzhun
BZ
+$8.18M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.91%
2 Technology 25.51%
3 Communication Services 14.94%
4 Healthcare 9.44%
5 Real Estate 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAWN
276
DELISTED
Day One Biopharmaceuticals
DAWN
$232K 0.02%
+10,764
New +$221K
HUM icon
277
Humana
HUM
$46.7B
$230K 0.02%
450
-73
-14% -$38.4K
CDMO
278
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$230K 0.02%
16,728
+4,749
+40% +$72.7K
DE icon
279
Deere & Co
DE
$170B
$229K 0.02%
+535
New +$217K
AVXL icon
280
Anavex Life Sciences
AVXL
$222M
$226K 0.02%
24,362
+5,547
+29% +$59.3K
FATE icon
281
Fate Therapeutics
FATE
$281M
$226K 0.02%
22,356
+5,404
+32% +$101K
GS icon
282
Goldman Sachs
GS
$313B
$226K 0.02%
+657
New +$229K
FUTU icon
283
Futu Holdings
FUTU
$13.9B
$225K 0.02%
+5,533
New +$270K
LMT icon
284
Lockheed Martin
LMT
$134B
$221K 0.02%
+454
New +$211K
AGEN
285
Agenus
AGEN
$249M
$220K 0.02%
4,673
-212
-4% -$10.8K
MS icon
286
Morgan Stanley
MS
$337B
$219K 0.02%
2,575
-194
-7% -$16.5K
CRWD icon
287
CrowdStrike
CRWD
$187B
$218K 0.02%
8,296
-256
-3% -$8.76K
KYNB
288
Kyntra Bio
KYNB
$28.5M
$218K 0.02%
544
-82
-13% -$31.4K
DCPH
289
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$217K 0.02%
13,239
-648
-5% -$10.5K
SIRI icon
290
SiriusXM
SIRI
$10B
$216K 0.02%
3,695
-66
-2% -$4.06K
SPGI icon
291
S&P Global
SPGI
$126B
$216K 0.02%
645
-42
-6% -$13.8K
KURA icon
292
Kura Oncology
KURA
$922M
$213K 0.02%
17,173
-2,207
-11% -$32.1K
INO icon
293
Inovio Pharmaceuticals
INO
$79.8M
$212K 0.02%
11,307
+667
+6% +$15.1K
MCK icon
294
McKesson
MCK
$98.5B
$211K 0.02%
563
-82
-13% -$30.6K
RCUS icon
295
Arcus Biosciences
RCUS
$3.57B
$211K 0.02%
10,214
-5,506
-35% -$152K
IMVT icon
296
Immunovant
IMVT
$8.09B
$209K 0.02%
+11,799
New +$149K
RXRX icon
297
Recursion Pharmaceuticals
RXRX
$1.57B
$209K 0.02%
27,111
+15,252
+129% +$150K
HPE icon
298
Hewlett Packard
HPE
$63.2B
$208K 0.02%
13,052
– –
HCA icon
299
HCA Healthcare
HCA
$84.8B
$207K 0.02%
+862
New +$193K
BLK icon
300
Blackrock
BLK
$164B
$206K 0.02%
+290
New +$194K
10 11
12
13 14

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, E Fund Management held 362 positions worth $1.2B, up 12% from $1.07B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

E Fund Management's Q4 2022 filing shows 28 new, 88 increased, 207 reduced and 28 closed positions. Its largest new stake was Akero Therapeutics: 9,604 shares worth $526K. The largest sale was KE Holdings, an estimated $21.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, up from 34% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q4 2022 buy was Akero Therapeutics: 9,604 shares worth $526K.
  • E Fund Management added most to Tencent Music in Q4 2022, an estimated $28.3M increase.
  • E Fund Management's biggest Q4 2022 reduction was KE Holdings, cutting an estimated $21.9M.
  • E Fund Management fully exited Li Auto in Q4 2022, selling an estimated $8.53M.
  • E Fund Management's ten largest holdings make up 57% of its $1.2B portfolio in Q4 2022.
  • E Fund Management opened 28 new positions and closed 28 in Q4 2022.
  • E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.2B.

Based on E Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.